Identification of lncRNA FAM83H-AS1 as a novel prognostic marker in luminal subtype breast cancer

BACKGROUND: Luminal subtype breast cancer accounts for a predominant number of breast cancers. Considering the heterogeneity of the disease, it is urgent to develop novel biomarkers to improve risk stratification and optimize therapy choices. Long non-coding RNA (lncRNA) represents an emerging and u...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Onco Targets Ther
Autors principals: Yang, Fan, Lv, Shi-Xu, Lv, Lin, Liu, Ye-Huan, Dong, Si-Yang, Yao, Zhi-Han, Dai, Xuan-xuan, Zhang, Xiao-Hua, Wang, Ou-Chen
Format: Artigo
Idioma:Inglês
Publicat: Dove Medical Press 2016
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5117955/
https://ncbi.nlm.nih.gov/pubmed/27895496
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S110055
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars